Brief: Herantis Pharma Commences Directed Share Issue, Contemplates Secondary Listing On Nasdaq First North Growth Market Sweden
11/11/2019 07:05
Nov 11 (Reuters) - Herantis Pharma Oyj HRTIS.HE :
* REG-HERANTIS PHARMA PLC COMMENCES A DIRECTED SHARE ISSUE,
CONTEMPLATES SECONDARY LISTING ON NASDAQ FIRST NORTH GROWTH
MARKET SWEDEN AND EXPANDS ITS MANAGEMENT TEAM
* DIRECTED SHARE ISSUE OF UP TO 360,000 NEW SHARES
* BOARD MAY INCREASE NUMBER OF OFFER SHARES OFFERED IN
PRIVATE
PLACEMENT BY A MAXIMUM OF 258,018 OFFER SHARES
* SUBSCRIPTION PRICE OF EACH OFFER SHARE IS SEK 71
* PURPOSE IS TO TO BROADEN SHAREHOLDER BASE IN ORDER TO
IMPLEMENT
TRADING ON NASDAQ FIRST NORTH GROWTH MARKET SWEDEN
Source text for Eikon: ID:nGNE4GfM2Z
Further company coverage: HRTIS.HE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))